Janet Liang
CIK: 0001888381
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 3, 2026OSCR
Oscar Health, Inc.
Sale(S)Direct10.4K shares at avg. $31.45$326K - Jun 2, 2026OSCR
Oscar Health, Inc.
Sale(S)Direct8.9K shares at avg. $21.74$194K - Jun 2, 2026OSCR
Oscar Health, Inc.
Sale(S)Direct3.5K shares at avg. $22.45$79K - Mar 2, 2026OSCR
Oscar Health, Inc.
Award(A)Direct106.5K shares- - Mar 2, 2026OSCR
Oscar Health, Inc.
Sale(S)Direct7.5K shares at avg. $13.39$100K - Dec 2, 2025OSCR
Oscar Health, Inc.
Sale(S)Direct7.3K shares at avg. $16.59$122K - Sep 2, 2025OSCR
Oscar Health, Inc.
Tax Payment(F)Direct7.3K shares at avg. $16.66$122K - Jun 2, 2025OSCR
Oscar Health, Inc.
Tax Payment(F)Direct7.2K shares at avg. $13.80$99K - Mar 5, 2025OSCR
Oscar Health, Inc.
Award(A)Direct97K shares- - Feb 24, 2025OSCR
Oscar Health, Inc.
Award(A)Direct97.4K shares- - Dec 31, 2024LNC
LINCOLN NATIONAL CORP
Award(A)DirectPhantom Stock Unit
2.3K shares at avg. $31.71- - Sep 30, 2024LNC
LINCOLN NATIONAL CORP
Award(A)DirectPhantom Stock Unit
2.3K shares at avg. $31.51-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 |  OSCR Oscar Health, Inc. | Sale(S) | 10,360 | $31.45 | $325,822 | Direct |
| Jun 2, 2026 | OSCR Oscar Health, Inc. | Sale(S) | 8,940 | $21.74 | $194,356 | Direct |
| Jun 2, 2026 | OSCR Oscar Health, Inc. | Sale(S) | 3,535 | $22.45 | $79,361 | Direct |
| Mar 2, 2026 | OSCR Oscar Health, Inc. | Award(A) | 106,458 | - | $0 | Direct |
| Mar 2, 2026 | OSCR Oscar Health, Inc. | Sale(S) | 7,453 | $13.39 | $99,796 | Direct |
| Dec 2, 2025 | OSCR Oscar Health, Inc. | Sale(S) | 7,338 | $16.59 | $121,737 | Direct |
| Sep 2, 2025 | OSCR Oscar Health, Inc. | Tax Payment(F) | 7,303 | $16.66 | $121,668 | Direct |
| Jun 2, 2025 | OSCR Oscar Health, Inc. | Tax Payment(F) | 7,196 | $13.80 | $99,305 | Direct |
| Mar 5, 2025 | OSCR Oscar Health, Inc. | Award(A) | 96,962 | - | - | Direct |
| Feb 24, 2025 | OSCR Oscar Health, Inc. | Award(A) | 97,402 | - | - | Direct |
| Dec 31, 2024 |  LNC LINCOLN NATIONAL CORP | Award(A) Phantom Stock Unit | 2,286 | $31.71 | - | Direct |
| Sep 30, 2024 | LNC LINCOLN NATIONAL CORP | Award(A) Phantom Stock Unit | 2,301 | $31.51 | - | Direct |
1-12 of 12 transactions
About Liang Janet
Liang Janet (SEC CIK 0001888381) files insider reports with the SEC as President, Oscar Insurance of Oscar Health, Inc. (OSCR) and Director of LINCOLN NATIONAL CORP (LNC).
Signal8 holds 11 ownership filings by Liang Janet (1 Form 3, 10 Form 4), filed between Oct 2, 2024 and Sep 8, 2026. Those filings report 12 transactions, from Sep 30, 2024 to Sep 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Liang Janet's filings is in NEW YORK, NY.
Recent filings by Liang Janet
- Sep 3, 2026: Open-market sale of OSCR shares (Form 4, code S).
- Jun 2, 2026: Open-market sales of OSCR shares (2 lines, Form 4, code S).
- Mar 2, 2026: Grant or award of OSCR shares (Form 4, code A).
- Mar 2, 2026: Open-market sale of OSCR shares (Form 4, code S).
- Dec 2, 2025: Open-market sale of OSCR shares (Form 4, code S).
Other insiders filing for Oscar Health, Inc. (OSCR)
- Plouffe David, Director
- Sankaran Sid, Director
- Gassen William, Director
- WITTMAN VANESSA AMES, Director
- Kushner Joshua, Co-Founder and Vice Chairman
- Thrive Partners II GP, LLC, Director